Who should receive vertebroplasty? by Satre, Thomas J. & Mackler, Leslie
VOL 55, NO 7 / JULY 2006 637www. j f p o n l i n e . c om
From the 
Family Physicians
Inquiries Network
CLINICAL INQUIRIES
Thomas J. Satre, MD
St. Cloud Hospital/
Mayo Family Medicine
Residency, St. Cloud, Minn
Leslie Mackler, MSLS
Moses Cones Health System
Library, Greensboro, NC
E V I D E N C E - B A S E D A N S W E R
C L I N I C A L C O M M E N TA R Y
Who should receive vertebroplasty?
z Evidence summary
No randomized controlled trials have
been published regarding percutaneous
vertebroplasty. A 2005 Technology
Assessment by the Centers for Medicare
and Medicaid Services (CMS) provides
the best evidence about indications and
efficacy of percutaneous vertebroplasty
for vertebral fractures.1 The CMS report
is based on a search of Medline and
Current Contents through April 2005 for
relevant studies, along with hand search-
es of retrieved articles’ references and of
recent pertinent journals. Study inclusion
criteria included English language, verte-
bral fractures due to osteoporosis or
malignancy, consecutive patient enroll-
ment, outcomes reported for pain, func-
tional status, and quality of life, and
study size ≥20 patients for studies of
osteoporosis or ≥10 patients for studies
of malignancy. There was no description
Percutaneous vertebroplasty has been
used to treat aggressive vertebral hem-
angiomas, osteoporotic vertebral compres-
sion fractures, and vertebral lesions from
metastatic disease or myeloma. Consider 
it for patients with severe acute or chronic
pain related to one of these lesions who
have failed a reasonable course of medical
therapy (strength of recommendation
[SOR]: B, based on structured reviews of
observational studies). Contraindications
include an uncorrectable coagulation 
disorder, infection in the area, spinal cord
compression, destruction of the posterior
wall of the vertebral body, and severe
degrees of vertebral body collapse (SOR:
B, based on structured reviews of observa-
tional studies). Pain relief from vertebroplas-
ty for osteoporotic vertebral fractures may
be less for older fractures (SOR: C).
Long-term sequelae of this procedure
are unknown, so proceed with caution
Vertebroplasty appears to be becoming the
standard of care for back pain due to 
compression fractures. It has become the
next step, in the absence of contraindica-
tions, when conservative measures fail. The
long-term sequelae of this relatively new
procedure are unknown, so it is prudent to
proceed with caution. I am following a few
patients who have had this procedure due
to osteoporotic vertebral fractures and back
pain. All are living remarkably pain-free lives.
Future studies should probably be
focused on the best types and the appro-
priate amount of bone cement to inject for
relief of pain symptoms and minimize leak-
age. Another important study would involve
comparing the clinical outcomes and 
long-term complications for patients who
have had vertebroplasty vs kyphoplasty.
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of a formal study validity assessment or
attempts to control bias by use of multi-
ple reviewers. 
Fifteen studies were included, repre-
senting 1056 patients. Fourteen of the
studies were observational and 1 was a
nonrandomized controlled trial. The
common inclusion requirement was
severe pain attributable to vertebral frac-
ture. Nine of the studies further specified
failure of analgesics or conservative
treatments. The studies showed statisti-
cally significant decreases in comparative
visual analog pain scale scores in the
short term. Four studies showed pain
reduction lasting up to 1 year. These
results favor the conclusion that percuta-
neous vertebroplasty provides short- and
long-term pain reduction for patients
meeting the inclusion criteria. However,
the lack of randomized trials cannot con-
trol for the placebo effect, the natural
history of vertebral fractures, and regres-
sion to the mean as possible reasons for
the apparent efficacy of percutaneous
vertebroplasty. 
Two structured, but not systematic,
reviews of percutaneous vertebroplasty in
vertebral fractures2,3 included 15 small
observational studies, of which only 1 was
included in the CMS report. These reviews
examined outcomes of vertebroplasty per-
formed from less than 1 month to a mean
of 7 months after fracture, using similar
inclusion criteria to those used in the CMS
report. The studies’ common patient exclu-
sion criteria were uncorrectable coagula-
tion disorder, infection in the area, spinal
cord compression, destruction of the pos-
terior vertebral wall, and severe degrees of
vertebral body collapse (defined as >67%
collapse). The 2 reviews found between
67% and 100% of patients reported pain
reduction after vertebroplasty in follow-up
periods ranging from 24 hours to up to 
10 years. Based on this limited evidence, 
1 review suggested that the likelihood of
alleviation of pain decreases over time and
is low for fractures occurring more than 
6 months in the past.3 In contradistinction,
3 subsequent observational studies,
involving a total of 233 patients with 365
vertebral compression fractures failed to
find an association between postprocedur-
al pain and age of fracture (ranging from
less than 2 weeks to more than 24 months
from injury).4–6
Recommendations from others
In their guideline on rehabilitation of the
patient with osteoporosis, the National
Osteoporosis Foundation states an experi-
enced practitioner may perform percuta-
neous vertebroplasty on a patient with
unremitting pain for whom conservative
medical therapy has not helped.7 They
qualify this recommendation by further
stating long-term clinical studies are
required before vertebroplasty becomes
standard of care. The Medicare Coverage
Advisory Committee, in its review of the
2005 CMS report, suggested that percuta-
neous vertebroplasty produces a clinically
important net health benefit for patients
with vertebral compression fracture com-
pared to conservative care for both acute
and chronic fractures.8
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Consider 
vertebroplasty 
for patients with
severe acute or
chronic pain 
related to vertebral
lesions when 
medical therapy
has failed
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